Patient Access Navigator

Benefits

Parental leave

Not verified not verified - source URL not recorded

Non-birth-parent leave

Not verified

Family-building benefits

• Fertility benefits: Not verified
• Adoption assistance: Not verified
• Surrogacy assistance: Not verified

Mental health support

Not verified

Relocation assistance

Not verified

Childcare support

Not verified

Learning budget

Offered From the posting source checked Jun 20, 2026

Verification

Not verified checked Jun 13, 2026

Salary

$170K-$200K From the posting source checked Jun 20, 2026

401(k) match

Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Market context

U.S. role benchmark (BLS OEWS)

$61,842 U.S. median for this role

Projected growth (BLS Employment Projections)

+1.9% - Slower

199% above the BLS role benchmark for operations aggregate.

Matched to SOC 11-1021 - Operations aggregate by role bucket.

Source: U.S. Bureau of Labor Statistics, OEWS, May 2024 and Employment Projections, 2024-2034.

Role

Role function

Operations From the posting source checked Jun 20, 2026

Seniority

Mid From the posting source checked Jun 20, 2026

Schedule

Shift type

Not verified

Weekend work

Not verified

Company

Equity

Offered Verified - SEC 10-K source checked Jun 20, 2026

Application

Cover letter

Not verified

Assessment

Not verified

Deadline

Not stated

Where they hire

State eligibility is not yet verified.

About this role

Patient Access Navigator Waltham, Massachusetts, United States Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing. The Role: Cogent Biosciences is searching for compassionate and highly motivated Patient Access Navigators to establish the inaugural Patient Services team. The Patient Access Navigators will be responsible for delivering a high-touch, patient-centered access experience across the prescription fulfillment journey. The Patient Access Navigator will own the end-to-end patient experience within an assigned geographic region and partners closely with patients, caregivers, healthcare providers (HCPs), specialty pharmacies, internal field teams, and external patient services partners to ensure timely access to therapy and continuity of care. While primarily remote/office-based (depending on location), the Patient Access Navigator will support limited non-promotional on-site visits to HCP offices, when appropriate, to support complex access, reimbursement or care coordination needs. The successful candidate will

Read the full description at job-boards.greenhouse.io. FewerJobs shows a preview and links to the original posting.